Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) EBITDA Margin (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) posted EBITDA Margin of -1050.49% for FY2024 (year ended Dec 31, 2024).

Analysis

Kazia Therapeutics (KZIA) EBITDA Margin (2009 - 2013) Analysis & Trends

Since FY2009, Kazia Therapeutics has reported EBITDA Margin for 14 fiscal years.

  • Annual EBITDA Margin shows a five-year change of -444.48 percentage points (FY2019 to FY2024).
  • The FY2024 figure stands as the highest annual EBITDA Margin since FY2021.
  • Business Quant data shows KZIA's EBITDA Margin at -50.31% in FY2021 (+1050.63 pp) and -1100.94% in FY2020 (-494.94 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 32.68%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 46.88%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 40.60%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 39.77%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 46.62%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 50.63%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 42.49%
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 -589.65%
Dec 31, 2012 -616.22%
Dec 31, 2009 -15.03%
API Access

Kazia Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY